Neurodiagnostics Market Size and Share

The neurodiagnostics market was valued at US$ 8.3 Billion in 2023 and is expected to register a CAGR of 7.1% over the forecast period and reach US$ 15.4 Bn in 2032.

Neurodiagnostics is the study and recording of electrical activity in the brain, central nervous system, and peripheral nervous system, and these recordings are used to gain crucial information, which can be used to assist in diagnosis and treatment of people with neurological problems, such as epilepsy, headaches, and head and spinal injuries, as well as seizures, sleep disorders, stroke, and coma.